Business

Ironwood Pharmaceuticals Q2 Loss of $0.28 Misses Street View

Ironwood Pharmaceuticals Q2 Loss of $0.28 Misses Street View

Ironwood Pharmaceuticals (IRWD) reported a Q2 non-GAAP net loss per share of $0.28, unchanged from the year-ago quarter but worse than the Capital IQ consensus forecast of a loss of $0.23. Revenue for the quarter was $81.1 million, up from $65.1 million during the same period last year, and below the analyst forecast of $82.6 million. Ironwood said it planned […]

Payrolls Miss Tempered by Upward Revisions

Payrolls Miss Tempered by Upward Revisions

The 157,000 July payroll gain undershot the 190,000 expected (with “whisper” numbers well above 200,000), but 59,000 in upward revisions left a slightly higher-than-expected July payroll level on net, just as hours-worked fell 0.2% in July after a sharp June boost to 0.5% from 0.2% also left that metric in line with July expectations. There was the expected 0.3% hourly […]